Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol RRM2B contributors: mct - updated : 22-10-2015
HGNC name ribonucleotide reductase M2 B (TP53 inducible)
HGNC id 17296
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
HOMOLOGY
intraspecies homolog to RRM2 (80p 100)
Homologene
FAMILY
  • ribonucleoside diphosphate reductase small chain family
  • CATEGORY enzyme
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm,organelle,mitochondria
    intracellular,cytoplasm,cytosolic
    intracellular,nucleus,nucleoplasm
    text
  • is expressed throughout the cell cycle and in quiescent cells where it provides dNTPs for mitochondrial DNA synthesis
  • basic FUNCTION
  • TP53-controled small ribonucleotide reductase, catalyzing the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides
  • direct interaction of TP53 with RRM2 and the nuclear accumulation of ribonucleotide reductase subunits after UV exposure might play a pivotal role in DNA repair
  • play essential roles in DNA repair, mtDNA synthesis, and protection against oxidative stress
  • play key roles in forming ribonucleotide reductase holoenzyme and supplying nucleotide precursors for DNA replication and repair
  • may play a key role in defending oxidative stress by scavenging ROS, and this antioxidant property is also important for its enzymatic activity
  • plays critical roles not only in DNA damage repair but also in proliferation of cancer cells
  • required for mitochondrial DNA replication and DNA repair in quiescent cells
  • in postmitotic mammalian cells, RRM2B substitutes for protein R2 as a subunit of ribonucleotide reductase
  • its activity is required for the stability of the mt genome in differentiated tissues, shifting the attention from DNA repair to mtDNA maintenance
  • DNA damage-inducible small subunit of ribonucleotide reductase, the rate-limiting enzyme in de novo deoxyribonucleoside triphosphate synthesis
  • plays a crucial role in maintaining chromosomal stability and preventing chronic-inflammation-associated tumorigenesis
  • its activity is a prosurvival function inactivated by proteolysis during apoptosis
  • critical ribonucleotide reductase (RR) subunit that exists as TP53-inducible and TP53-dependent molecule
  • critical role of RRM2B in mitochondrial homeostasis and the inflammation signaling pathway in a TP53-independent manner
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
  • heterodimer of a large (M1) and a small chain (M2)
  • INTERACTION
    DNA
    RNA
    small molecule metal binding,
  • binds 2 iron ions per subunit
  • protein
  • interacting with RRM1
  • direct interaction with TP53 and RRM2
  • TP53-inducible ribonucleotide reductase
  • RRM2B as well as its heterodimeric partner RRM1, are associated with ATM
  • MAP2K2 is an endogenous regulator of RRM2B, suggesting that it may associate with RRM2B and upregulate its activity
  • transcriptionally and functionally regulated independent of TP53 pathway by FOXO3
  • role of E2F1 in the regulation of RRM2B expression in DNA damage response (DDR)
  • FOXO3 was identified as a novel regulator of RRM2B
  • cell & other
    REGULATION
    induced by by ultraviolet light in a p53-dependent manner
    by stress signals prior to the onset of senescence and prevents premature oxidative stress-induced senescence
    Other regulated by p53 for supplying nucleotides to repair damaged DNA
    regulation of its activity via ATM-mediated phosphorylation at Ser(72) and MDM2-dependent turnover of RRM2B dephosphorylated at the same residue
    ASSOCIATED DISORDERS
    corresponding disease(s) MDDS5 , PEO5
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    significantly correlated with depth of invasion, lymph node metastasis, stage, and poor prognosis, in esophageal squamous cell carcinoma
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    cancer  
    is a potential target for cancer therapy
    cancer  
    potential target for anticancer drugs as well as a diagnostic marker in cancer
    ANIMAL & CELL MODELS